Sources: FactSet, Tullett Prebon, Currencies: Currency quotes are updated in real-time. Sources: FactSet, Dow Jones, Stock Movers: Gainers, decliners and most actives market activity tables are a combination of NYSE, Nasdaq, NYSE American and NYSE Arca listings. Cryptocurrencies: Cryptocurrency quotes are updated in real-time. Digging deeper we become aware of the PEG ratio of the GLPG stock which is currently positioned at 0. The average estimate is representing an increase of -0.9% in sales growth from that of posted by the company in the same quarter of last year. On the other hand, the S&P 500 Index was up 0.74% in the last trading session while the Dow Jones Industrial closed the session higher at 0.66%. In April the standing of shares short declined as it was 972.82 Million in the previous month. Required fields are marked *. LAST CLOSE: €63.1. According to TipRanks.com, Guekam is a 3-star analyst with an average return of 5.2% and a 37.6% success rate. The price target was set to $ 270.00. Analysts are in estimates of -$1.32 per share for company’s earnings in the current quarter and are expecting its annual EPS growth moving up to -$4.95 for 2021 with estimates of that growing to -$4.55 in next year. The average 12 month price objective among analysts that have issued a report on the stock in the last year is $141.38. McCarthy covers the Healthcare sector, focusing on stocks such as Brainstorm Cell Therapeutics, Lineage Cell Therapeutics, and Monopar Therapeutics Inc. Galapagos has an analyst consensus of Moderate Buy, with a price target consensus of $101.77, … Any copying, republication or redistribution of Lipper content, including by caching, framing or similar means, is expressly prohibited without the prior written consent of Lipper. We use cookies and browser capability checks to help us deliver our online services, including to learn if you enabled Flash for video or ad blocking. The trading price of APA Corporation (NASDAQ:APA) floating lower at last check on Wednesday, May 19, closing at $21.67, -2.86% lower than its previous close. A number of equities analysts have weighed in on the company. With its current market valuation of $4.92 Billion, Galapagos NV is set to declare its quarterly results next month. GLPG.NL updated stock price target summary. Considering stock’s 52-week price range provides that GLPG hit a high price of $233.14 and saw its price falling to a low level of $74.51 during that period. Spero Therapeutics (NASDAQ:SPRO) initiated with Buy rating and $27 (170% upside) price target at Janney Montgomery Scott. Cantor Fitzgerald analyst Eliana Merle increased her price target on Galapagos to $188 from $130, and reiterated her Overweight rating in response to the news. This suggests a … Company’s P/E ratio for the trailing 12 months is 0. Having a second look at Galapagos NV (NASDAQ:GLPG) provides that stock’s average daily trading volume for 3 months was 309.23 Million, while it jumped to 319.45 Million when we calculate an average volume for past 10 days. Source: FactSet, Markets Diary: Data on U.S. Overview page represent trading in all U.S. markets and updates until 8 p.m. See Closing Diaries table for 4 p.m. closing data. Galapagos has an analyst consensus of Hold, with a price target consensus of $101.24. Their average twelve-month price target is $143.82, predicting that the stock has a possible upside of 92.01%. Citizens Financial Group, Inc.: Is CFG Stock Worth Buying? The analysts of H.C. Wainwright & Co. have rated Galapagos NV (spons ADRs with a Buy rating. Source: FactSet. Their forecasts range from $94.00 to $290.00. That average ranking earns GLPG an Analyst Rating of 18, which is better than 18% of stocks based on data compiled by InvestorsObserver. Industry’s another major player Bristol-Myers Squibb Company (BMY) has fell -0.03% down in previous session, but over the past year has faced a rise of 5.57%, while Gilead Sciences Inc (GILD) was also down -1.47% however its price remained floating in the red at -66.84% over the same period. Data compiled by Thomson Reuters highlights that percentage of outstanding shares held by the insiders is 0% while it is 8.59% for the institutional holders. Sources: FactSet, Dow Jones, ETF Movers: Includes ETFs & ETNs with volume of at least 50,000. In a report … GALAPAGOS NV : Financial analyst guidance for GALAPAGOS NV Stock | Euronext Amsterdam: GLPG | Euronext Amsterdam ... GALAPAGOS : RBC Capital Adjusts Galapagos' Price Target to $127 From $131, Main.. MT. News Corp is a global, diversified media and information services company focused on creating and distributing authoritative and engaging content and other products and services. On average, they anticipate Galapagos' stock price to reach $143.82 in the next twelve months. Your email address will not be published. These estimates are suggesting current year growth of -0.12% for EPS and -0.08% growth next year. Based on analysts offering 12 month price targets for GLPG in the last 3 months. Galapagos is a Belgium based biotech with a pipeline focused on autoimmune and inflammatory disease. By using our website or by closing this message box, you agree to our use of browser capability checks, and to our use of cookies as described in our Cookie Policy. Drop of -24.19% by stock’s current price to its year-to-date value in last trading session is likely to be increasing investors’ worries about the stock as it is hinting a further drop. According to TipRanks.com, Gerberry is currently ranked with 0 stars on a 0-5 stars ranking scale, with an average return of -3.1% and a 40.4% success rate. Leone covers the Healthcare sector, focusing on stocks such as Adverum Biotechnologies, Tarsus Pharmaceuticals, and Allogene Therapeutics. … It further provides that stock’s current price level is -5.41% away from its 20-day simple moving average and is -6.43% off its SMA50. A number … Source: Kantar Media, GLPG will report FY 2022 earnings on 02/24/2022, GLPG will report Q2 earnings on 08/05/2021. Morgan Stanley decreased their price target on Galapagos from $129.00 to $117.00 and set an “overweight” rating for the company in a report on Thursday, March 11th. Galapagos (NASDAQ:GLPG) had its price target cut by Morgan Stanley from $129.00 to $117.00 in a report issued on Wednesday morning, Benzinga reports. Additionally, the information contained in their reports may not be correct or current. Change value during the period between open outcry settle and the commencement of the next day's trading is calculated as the difference between the last trade and the prior day's settle. APA Corporation (NASDAQ:APA): Hidden Gems in a Time of Volatility. Fundamental company data and analyst estimates provided by FactSet. Get the hottest stocks to trade every day before the market opens 100% free. GLPG Stock’s Forward Dividend of 0 and its yield of 0% are making investors’ thoughts stronger that it could fall further before the company announces its earnings for the current quarter. In comparing Galapagos NV (GLPG)’s stock with other industry players reveals that stock’s current price change of -1.47% and that of -66.84% over the past 12 months is in competing position with that of Amgen Inc (AMGN) which saw its stock price raised by 1.16% in the last trading and went through an increase of 8.95% in past 12-month trading. Merrill Lynch analyst Jason Gerberry maintained a Sell rating on Galapagos today and set a price target of $134.00. TARGET PRICE: OVERVIEW. ET by Tomi Kilgore Galapagos downgraded to neutral from overweight at J.P. Morgan ADRs) Analyst: Goldman Sachs Price Target: - Current Rating: Sell: Price*: 108.00 € Distance to Target Price*: Latest Analyst Research & Price Targets for Galapagos NV (GLPG-Q). ( See Galapagos stock analysis on TipRanks ) Disclosure: On the date of publication, Alexander Poulos did not have (either directly or indirectly) any positions in the securities mentioned in this article. The average price target is $140.625, which means analysts expect the stock to increase by 68.29% over the next twelve months. Get Notified Of Insider Trades, Analyst Upgrades & Downgrades, Earnings Updates & Best Stocks To Trade Every Single Morning, Join now to get the Newsheater.com pre-market morning brief 100% free. The Gilead, Galapagos Analyst: Matthew Harrison upgraded Gilead from Equal-weight from Overweight and increased the price target from $67 to $83. Join now to get the NewsHeater.com pre-market morning brief 100% free. In reaction to the Sept. 25 updates, Stifel Nicolaus analyst Derek Archila reiterated a Hold rating for Galapagos with a price target of $155. Recommendation by 1 analysts for the stock is an Outperform while number of those analysts who rated the stock as Underperform is none, whereas 2 of them are considering the stock as a Sell. GALAPAGOS NV : Financial analyst guidance for GALAPAGOS NV Stock | Euronext Amsterdam: GLPG | Euronext Amsterdam. When taken as whole, stock gets a rating of Hold and that encourages the investors to exploit the opportunity and build their stake up in the company. The company’s shares closed last Friday at $75.04, close to its 52-week low of $73.81. GALAPAGOS NV analysts consensus, targets, ratings and recommendations | Euronext Amsterdam: GLPG | Euronext Amsterdam Data are provided 'as is' for informational purposes only and are not intended for trading purposes. Change value during other periods is calculated as the difference between the last trade and the most recent settle. Copyright © FactSet Research Systems Inc. All rights reserved. 5 Stocks Under $10 That Are Poised to Take Off. Barclays analyst Rosie Turner upgraded Galapagos to Overweight from Equal Weight with a price target of EUR 80.00 up from EUR 69.00 The analyst says the company's early stage pipeline is underappreciated at current share levels following a deep dive on TYK2. The Blackstone Group Inc. (NYSE:BX): Should Value Hunters Buy It? The average rating presented in the last row of the above table above is from 1 to 5 where 1 is Strong Buy and 5 is Strong Sell. Its relative strength index (RSI) for 14-periods is oscillating at 35.39 while volatility remained at 2.34% over the past week which changes to 1.92% when measuring it over the past month. Number of outstanding shares of the stock stood at 65.51 Million. The analyst said although the … Stock Target Advisor runs millions of automatic calculations on over 75,000 stocks in American, Asian and European Exchanges and compares it with market analyst stock ratings and target stock prices to help you make smart investment decisions and build robust investment portfolios. Galapagos (GLPG) Kepler Capital analyst Arsene Guekam maintained a Hold rating on Galapagos on May 7 and set a price target of EUR79.00. Q3 2019 was a historic quarter for Galapagos, starting a long-term collaboration with Gilead Sciences. International stock quotes are delayed as per exchange requirements. The average analyst price target of $105.21 implies upside potential of around 22% from current levels over the next 12 months. Lipper shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon. FactSet (a) does not make any express or implied warranties of any kind regarding the data, including, without limitation, any warranty of merchantability or fitness for a particular purpose or use; and (b) shall not be liable for any errors, incompleteness, interruption or delay, action taken in reliance on any data, or for any damages resulting therefrom. In predicting price targets of as low as $73.4 and as high as $133.56, analysts are in agreement on assigning the stock over the next 12 months average price target of $94.68. The figures also indicate that as of April 14, 2021, number of stock’s short shares was 1130000 which implies a short ratio of 3.96. This shows up a 1.72% of Short Interest in company’s outstanding shares on the day. Galapagos Nv's average analyst price target is higher than 95.01% of Pharmaceutical Products stocks. Stock’s current price level is -2.19% above from estimated low price target while it is 77.99% below the estimated high; and even if the GLPG’s share succeeded to reach the median price of $92.77, then the outlook of +23.63% could come to the excitement of the investors. The company’s shares closed last Thursday at $143.52. Source: FactSet, Indexes: Index quotes may be real-time or delayed as per exchange requirements; refer to time stamps for information on any delays. 12 Wall Street analysts have set twelve-month price targets for Galapagos in the last year. Merle also reiterated a Neutral rating on Galapagos … According to ratings assigned by 18 analysts at the scale of 1 to 5 with 1.00 representing a strong buy and 5.00 suggesting a strong sell; 11 of them are recommending Galapagos NV (GLPG) as a Hold, while 4 are in view that stock is a Buy. In contrast, when we review GLPG stock’s current outlook then short term indicators are assigning it an average of 100% Sell, while medium term indicators are categorizing the stock at an average of 100% Sell. Galapagos Nv's number of analysts covering the stock is higher than 93.98% of Pharmaceutical Products stocks. For the GLPG price target at the top of this page, we present the average GLPG target price across the 6 analysts covering GLPG, as reported in data provided by Zacks Investment Research via Quandl.com.The median GLPG price target (a different metric than … According to . All rights reserved. 8 Wall Street analysts that have issued a 1 year GLPG price target, the average GLPG price target is $141.25, with the highest GLPG stock price forecast at $193.00 and the lowest GLPG stock price forecast at $100.00. Over a period of past 1-month, stock came losing -3.66% in its value. Galapagos has an analyst consensus of Hold, with a price target consensus of $233.88, which is a -6.3% downside from current levels. The average price target is $218.875, which means analysts expect the stock to climb by 59.19% over the next twelve months. The average price target is $ 0.00 with a high estimate of $ 0.00 and a low estimate of $ 0.00 . Add them to your watchlist before they take off! Here’s Why The Goldman Sachs Group, Inc. (NYSE:GS) is an Attractive Investment Right Now. Long term indicators are suggesting an average of 100% Sell for it. The trading price of The Blackstone Group Inc. (NYSE:BX) floating lower at last check on Wednesday, May 19, closing at $88.09, -0.69% lower than its, The trading price of The Goldman Sachs Group, Inc. (NYSE:GS) floating lower at last check on Wednesday, May 19, closing at $364.56, -1.96% lower than, The trading price of Citizens Financial Group, Inc. (NYSE:CFG) floating lower at last check on Wednesday, May 19, closing at $49.64, -1.89% lower than its. In predicting price targets of as low as $73.4 and as high as $133.56, analysts are in agreement on assigning the stock over the next 12 months average price target of $94.68. At a current price … Beta is valued at 0, while measure of average true range or ATR is currently at 1.94. Galapagos NV (NASDAQ:GLPG) concluded the trading at $75.04 on Friday, May 07 with a fall of -1.47% from its closing price on previous day. Galapagos Nv's variance in analysts' estimates is lower than 14.12% of all US stocks. Galapagos (NASDAQ:GLPG) Price Target and Consensus Rating 18 Wall Street analysts have issued ratings and price targets for Galapagos in the last 12 months. What is the outlook for GLPG? Analyst Coverage. Summary. Mutual Funds & ETFs: All of the mutual fund and ETF information contained in this display, with the exception of the current price and price history, was supplied by Lipper, A Refinitiv Company, subject to the following: Copyright © Refinitiv. UBS analyst Laura Sutcliffe raised the price target on Galapagos NV (GLPG:NA) (NASDAQ: GLPG) to EUR77.00 (from EUR75.00) while maintaining a Neutral rating. On average, analysts give GLPG a Buy rating. … Analysts watching the company’s growth closely have provided estimates for its revenue growth with an average revenue estimate of $127.63 Million. 18 equities research analysts have issued 1-year price targets for Galapagos' shares. Your email address will not be published. The views expressed by analysts in their coverage of Galapagos are those of the author and do not reflect the views of Galapagos. Sources: CoinDesk (Bitcoin), Kraken (all other cryptocurrencies), Calendars and Economy: 'Actual' numbers are added to the table after economic reports are released. Sources: FactSet, Dow Jones, Bonds: Bond quotes are updated in real-time. Galapagos stock price target raised to $298 from $188 at Stifel Nicolaus Feb. 24, 2020 at 9:02 a.m. The analysts below follow Galapagos. Galapagos NV has a P/E ratio of 0 against that of Amgen Inc’s 21.05 while Bristol-Myers Squibb Company is showing 0 for the same. Taking a look at stock we notice that its last check on previous day was $76.16 and 5Y monthly beta was reading 0 with its price kept floating in the range of $73.81 and $78.05 on the day. In keeping analyst consensus estimate with, company is forecasted to be making an annual revenue of $586.51 Million in 2021, which will be -8.1% less from revenue generated by the company last year. Company: Galapagos NV (spons. Save my name, email, and website in this browser for the next time I comment. They suggested that in the process company could generate revenue of as low as $51.84 Million which could climb up to $193.5 Million to hit a high. Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. Data may be intentionally delayed pursuant to supplier requirements. Click here now. Analyst. Analyst Ratings For GALAPAGOS NV/S ADR (NASDAQ:GLPG) Today, HC Wainwright reiterated its Buy rating on GALAPAGOS NV/S ADR (NASDAQ:GLPG) with a price target of $150.00. That average ranking earns GLP Cantor Fitzgerald analyst Eliana Merle reiterated an Overweight rating on Gilead and reduced the price target from $86 to $84. Galapagos N.V. analyst ratings, historical stock prices, earnings estimates & actuals. According to TipRanks.com, Leone is a 5-star analyst with an average return of 18.2% and a 65.8% success rate. On average, analysts give GLPG a Buy rating. They currently have an overweight rating on the biotechnology company’s stock. Sources: FactSet, Tullett Prebon, Commodities & Futures: Futures prices are delayed at least 10 minutes as per exchange requirements. We do not sell or share your information with anyone. Wall Street is positive on GALAPAGOS NV/S ADR (GLPG).

Late 2011 Macbook Pro Graphics Card, Thailand Flight Tickets, Best Indoor Tennis Courts, Slow Goodbye Songs, Patient In French Google Translate, Holy Envy Pdf, Databricks Tutorial Youtube, Blues Playoffs 2021, Affaire Grégory Est Républicain, Paysafecard Code Generator 2021, Dbh Sharks Basketball,